Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 28 04:00PM ET
67.32
Dollar change
-0.30
Percentage change
-0.44
%
IndexRUT P/E- EPS (ttm)-2.78 Insider Own29.24% Shs Outstand44.11M Perf Week12.26%
Market Cap3.28B Forward P/E- EPS next Y-2.55 Insider Trans-4.80% Shs Float34.44M Perf Month4.55%
Income-129.53M PEG- EPS next Q-0.63 Inst Own81.12% Short Float10.33% Perf Quarter26.52%
Sales47.17M P/S69.46 EPS this Y-49.59% Inst Trans16.98% Short Ratio6.29 Perf Half Y87.63%
Book/sh5.47 P/B12.31 EPS next Y-16.05% ROA-27.22% Short Interest3.56M Perf Year139.91%
Cash/sh9.03 P/C7.45 EPS next 5Y- ROE-51.56% 52W Range26.32 - 67.80 Perf YTD21.30%
Dividend Est.- P/FCF31.39 EPS past 5Y- ROI-40.48% 52W High-0.71% Beta0.04
Dividend TTM- Quick Ratio2.84 Sales past 5Y0.00% Gross Margin94.46% 52W Low155.78% ATR (14)2.92
Dividend Ex-Date- Current Ratio2.84 EPS Y/Y TTM32.74% Oper. Margin-307.14% RSI (14)62.67 Volatility4.39% 4.73%
Employees98 Debt/Eq0.41 Sales Y/Y TTM- Profit Margin-274.59% Recom1.14 Target Price67.17
Option/ShortYes / Yes LT Debt/Eq0.20 EPS Q/Q61.66% Payout- Rel Volume0.90 Prev Close67.62
Sales Surprise214.47% EPS Surprise178.87% Sales Q/Q- EarningsFeb 28 AMC Avg Volume565.35K Price67.32
SMA206.43% SMA5015.33% SMA20054.49% Trades Volume510,946 Change-0.44%
Date Action Analyst Rating Change Price Target Change
Jan-04-24Reiterated Needham Buy $65 → $71
Dec-19-23Initiated Scotiabank Sector Outperform $66
Oct-30-23Initiated TD Cowen Outperform
Oct-17-23Initiated UBS Buy $52
May-18-23Initiated Truist Buy $60
Apr-14-23Initiated Robert W. Baird Outperform $39
Mar-14-23Initiated Stifel Buy $43
Feb-13-23Initiated H.C. Wainwright Buy $42
Dec-13-22Resumed BofA Securities Buy $29 → $37
Oct-31-22Initiated Guggenheim Buy $36
Today 07:30PM
04:00PM
Feb-15-24 11:57AM
Jan-16-24 01:51PM
Dec-22-23 01:30AM
05:04PM Loading…
Dec-15-23 05:04PM
Dec-08-23 04:00PM
Nov-30-23 09:37PM
Nov-21-23 08:00AM
Nov-16-23 10:10AM
Nov-15-23 04:05PM
09:47AM
09:22AM
07:16AM
06:00AM
06:00AM Loading…
06:00AM
Nov-13-23 04:47PM
04:00PM
Nov-09-23 11:14AM
08:30AM
Nov-02-23 09:40AM
09:00AM
Oct-26-23 04:00PM
Oct-23-23 02:50AM
Oct-17-23 09:40AM
Sep-29-23 12:43PM
Sep-04-23 09:55AM
Sep-01-23 09:18AM
Aug-17-23 09:55AM
Aug-16-23 01:21PM
04:00PM Loading…
Aug-14-23 04:00PM
Jul-31-23 07:13AM
Jul-25-23 02:37AM
Jun-26-23 12:48PM
Jun-22-23 11:04AM
Jun-21-23 10:38AM
Jun-20-23 04:05PM
Jun-19-23 07:46PM
May-11-23 10:45AM
May-10-23 06:11AM
May-08-23 05:15PM
04:00PM
May-04-23 04:59AM
May-03-23 06:44AM
Apr-28-23 03:34PM
Apr-25-23 12:00PM
Apr-21-23 12:00PM
Apr-13-23 04:01PM
Apr-11-23 10:00AM
Apr-05-23 09:55AM
Apr-04-23 12:20PM
Apr-03-23 08:34AM
Mar-29-23 05:25PM
04:01PM
Mar-16-23 12:18PM
Feb-21-23 04:00PM
Feb-02-23 04:00PM
Jan-30-23 09:00AM
Jan-04-23 11:45AM
Dec-14-22 10:24AM
Dec-12-22 10:55AM
Dec-09-22 04:08PM
09:54AM
09:42AM
08:46AM
08:17AM
08:17AM
08:15AM
Nov-30-22 11:08AM
Nov-14-22 04:00PM
01:13PM
Oct-27-22 02:37PM
Sep-08-22 09:55AM
Aug-15-22 04:00PM
Aug-01-22 08:00AM
Jun-23-22 10:50AM
Jun-21-22 04:05PM
04:01PM
Jun-15-22 10:47PM
Jun-10-22 05:00PM
Jun-06-22 04:09PM
Jun-03-22 04:00PM
May-27-22 09:57AM
May-23-22 04:05PM
May-16-22 04:01PM
May-12-22 04:01PM
May-10-22 04:01PM
May-09-22 04:01PM
10:00AM
May-05-22 04:01PM
Apr-27-22 10:00AM
Apr-08-22 01:00PM
Mar-24-22 04:01PM
Mar-10-22 04:26PM
Mar-08-22 05:25PM
Feb-08-22 04:01PM
01:54PM
Feb-04-22 05:03PM
02:49PM
01:57AM
Arcellx, Inc is a clinical-stage biotechnology company, which provides cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. The company was founded by David M. Hilbert and Luba Zaritskaya in December 2014 and is headquartered in Gaithersburg, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Elghandour RamiSEE REMARKSFeb 12Sale64.4611,169719,94892,339Feb 12 07:43 PM
Heery ChristopherCHIEF MEDICAL OFFICERFeb 12Sale64.462,967191,25130,303Feb 12 07:46 PM
Elghandour RamiSEE REMARKSFeb 09Sale63.4013,886880,340103,508Feb 12 07:43 PM
Heery ChristopherCHIEF MEDICAL OFFICERFeb 09Sale63.403,688233,81133,270Feb 12 07:46 PM
Elghandour RamiSEE REMARKSFeb 08Sale62.2913,010810,451117,394Feb 12 07:43 PM
Heery ChristopherCHIEF MEDICAL OFFICERFeb 08Sale62.293,456215,29036,958Feb 12 07:46 PM
Heery ChristopherCHIEF MEDICAL OFFICERFeb 07Option Exercise0.0022,555040,414Feb 09 04:08 PM
Elghandour RamiSEE REMARKSFeb 07Option Exercise0.0070,2110130,404Feb 09 04:05 PM
Elghandour RamiSee RemarksJan 04Sale55.2729,0731,606,80460,193Jan 08 04:02 PM
Gilson MichelleChief Financial OfficerJan 04Sale55.278,514470,55116,310Jan 08 04:04 PM
Heery ChristopherChief Medical OfficerJan 04Sale55.277,598419,92617,859Jan 08 04:06 PM
Heery ChristopherChief Medical OfficerJan 03Option Exercise0.0016,519025,457Jan 04 07:32 PM
Elghandour RamiSee RemarksJan 03Option Exercise0.0053,097089,266Jan 04 07:29 PM
Heery ChristopherChief Medical OfficerDec 18Option Exercise6.28120,000753,600127,795Dec 19 04:43 PM
Heery ChristopherChief Medical OfficerDec 18Sale50.17120,0006,020,2817,795Dec 19 04:43 PM
Carroll JillDirectorDec 14Sale49.13504,26324,774,4411,983,411Dec 18 04:47 PM
Heery ChristopherChief Medical OfficerAug 04Option Exercise15.003,00045,00010,795Aug 07 04:51 PM
Heery ChristopherChief Medical OfficerAug 04Sale35.383,000106,1337,795Aug 07 04:51 PM
Heery ChristopherChief Medical OfficerJul 03Option Exercise15.003,00045,00010,795Jul 05 08:06 PM
Heery ChristopherChief Medical OfficerJul 03Sale31.753,00095,2467,795Jul 05 08:06 PM
Carroll JillDirectorJun 01Sale44.3525,5561,133,3172,487,674Jun 02 04:56 PM
Carroll JillDirectorMay 31Sale41.50315,16413,079,3062,513,230Jun 02 04:56 PM
Elghandour RamiSee RemarksMay 31Sale44.272,600115,09936,169Jun 02 05:10 PM
Gilson MichelleChief Financial OfficerMay 25Sale42.776,000256,6169,485May 25 08:21 PM
Gilson MichelleChief Financial OfficerMay 24Sale42.468,704369,53415,485May 25 08:21 PM
Gilson MichelleChief Financial OfficerMay 23Option Exercise0.0022,428024,189May 25 08:21 PM
SR ONE CAPITAL MANAGEMENT, LLC10% OwnerMay 11Sale45.011,012,83345,589,3171,658,780May 15 06:16 PM
Carroll JillDirectorMay 11Sale45.01638,41728,736,2232,828,394May 15 06:18 PM
Heery ChristopherChief Medical OfficerMay 10Sale45.182,19799,2667,795May 11 04:10 PM
Heery ChristopherChief Medical OfficerMay 09Sale45.0050022,5009,992May 11 04:10 PM
Heery ChristopherChief Medical OfficerMay 05Sale45.001,20054,00210,492May 08 06:50 PM
Heery ChristopherChief Medical OfficerMay 03Option Exercise15.003,00045,00014,692May 05 04:10 PM
Heery ChristopherChief Medical OfficerMay 03Sale43.443,000130,32911,692May 05 04:10 PM
Heery ChristopherChief Medical OfficerApr 24Option Exercise10.6420,000212,80031,692Apr 26 04:11 PM
Heery ChristopherChief Medical OfficerApr 24Sale40.0020,000800,06811,692Apr 26 04:11 PM
Heery ChristopherChief Medical OfficerApr 19Option Exercise13.1612,345162,50327,334Apr 20 04:09 PM
Heery ChristopherChief Medical OfficerApr 19Sale35.0115,642547,66111,692Apr 20 04:09 PM
Heery ChristopherChief Medical OfficerApr 18Option Exercise10.165,40054,84020,989Apr 20 04:09 PM
Heery ChristopherChief Medical OfficerApr 18Sale35.006,000210,00014,989Apr 20 04:09 PM
Heery ChristopherChief Medical OfficerApr 03Option Exercise15.003,00045,00018,589Apr 04 07:35 PM
Heery ChristopherChief Medical OfficerApr 03Sale30.713,00092,12115,589Apr 04 07:35 PM